Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom
allergy are well established; however, clinical contraindications to AIT are not always well …

Hymenoptera venom allergy is a potentially life‐threatening allergic reaction following a
honeybee, vespid, or ant sting. Systemic‐allergic sting reactions have been reported in up to …

Abstract The World Allergy Organization (WAO) Guidelines for the assessment and
management of anaphylaxis provide a unique global perspective on this increasingly …

Although the ideal type of reference would consist of a randomized, double-blind, placebo-
controlled study, the topic of this practice parameter is represented by very few such studies …

One of the major concerns in the practice of allergy is related to the safety of procedures for
the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of …

This practice parameter update focuses on 7 areas in which there are new evidence and
new recommendations. Diagnostic criteria for anaphylaxis have been revised, and patterns …

Hymenoptera venom allergy is an epidemiologically underestimated condition representing
an important cause of morbidity worldwide. Preventing future allergic reactions in patients …

Allergic reactions to stings of Hymenoptera species may be severe and are potentially fatal
deviations of the immunological response observed in healthy individuals. However, venom …

Hymenoptera stings may cause both local and systemic allergic reactions and even life
threatening anaphylaxis. Along with pharmaceutical drugs and foods, hymenoptera venom …